Session 4: What should we do for poor responders after chemoradiotherapy: bad biology or should the fight go on?

Bhoday, J., Glimelius, B., Tait, D., Glynne-Jones, R., Adams, R. ORCID: https://orcid.org/0000-0003-3915-7243 and Brown, G. 2018. Session 4: What should we do for poor responders after chemoradiotherapy: bad biology or should the fight go on? Presented at: Future Horizons International Experts Meeting in Colorectal Cancer 2015, London, England, 25 June 2015. Published in: Wale, Anita and Brown, Gina eds. Colorectal Disease. , vol.20 (S`) Wiley, pp. 97-99. 10.1111/codi.14088

Full text not available from this repository.

Abstract

Just over 50% of patients with advanced rectal cancer have a poor response to chemoradiotherapy with resultant poor outcomes. Professor Glimelius reviews the evidence base for defining such patients and the potential role, if any, of further treatment.

Item Type:	Conference or Workshop Item (Paper)
Date Type:	Publication
Status:	Published
Schools:	Schools > Medicine Research Institutes & Centres > Centre for Trials Research (CNTRR)
Publisher:	Wiley
ISSN:	1462-8910
Last Modified:	09 Nov 2022 10:54
URI:	https://orca.cardiff.ac.uk/id/eprint/141058

Citation Data

Cited 1 time in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item